Inhibition of hind-paw edema and cutaneous vascular plasma extravasation in mice by acetylshikonin.
Acetylshikonin, a naphthoquinone isolated from the Chinese herb medicine, tzu ts'ao, was demonstrated to inhibit the polymyxin B-induced hind-paw edema in normal as well as in adrenalectomized mice. Liver glycogen content was increased in adrenalectomized mice pretreated with dexamethasone, but not with acetylshikonin. Like diphenhydramine, methysergide and isoproterenol, acetylshikonin reduced the plasma exudation evoked in dorsal hind-paw skin by antidromic stimulation of the saphenous nerve, and in passive cutaneous anaphylactic reaction, bradykinin-, substance P-, compound 48/80-, histamine- and serotonin-induced ear edema. Indomethacin was ineffective in these respects. Bradykinin- and substance P-induced plasma exudation were also significantly reduced when [Thi5,8,D-Phe7]bradykinin and [D-Pro2,D-Trp7,9]substance P were coinjected with bradykinin and substance P, respectively. In isolated rat peritoneal mast cell preparation, acetylshikonin produced a concentration-dependent inhibition of histamine and beta-glucuronidase release from mast cells challenged by compound 48/80. In compound 48/80-pretreated mice, acetylshikonin and isoproterenol produced significantly more inhibitory effect on bradykinin- and substance P-induced plasma exudation than did diphenhydramine in combination with methysergide. Pretreatment with diphenhydramine/methysergide in compound 48/80-pretreated mice significantly further reduced the bradykinin- and substance P-induced plasma exudation if [Thi5,8,D-Phe7]bradykinin and [D-Pro2,D-Trp7,9]substance P were coinjected with bradykinin or substance P, respectively. The results suggest that the inhibitory effect of acetylshikonin on the edematous response is due neither to the release of steroid hormones from the adrenal gland nor to the glucocorticoid activity, but probably partly to the suppression of mast cell degranulation and partly to protection of the vasculature from mediator challenge.
Wang
J P
JP
Department of Medical Research, Taichung Veterans General Hospital, Taiwan.
Raung
S L
SL
Chang
L C
LC
Kuo
S C
SC
D000315:Adrenalectomy; D000818:Animals; D000880:Anthraquinones / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001920:Bradykinin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology / Q000633:toxicity; D002199:Capillary Permeability / Q000187:drug effects*; D015550:Cell Degranulation / Q000187:drug effects; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology; D004155:Diphenhydramine / Q000008:administration & dosage / Q000494:pharmacology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004365:Drugs, Chinese Herbal / Q000494:pharmacology* / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D005966:Glucuronidase / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006614:Hindlimb; D006632:Histamine / Q000378:metabolism; D007213:Indomethacin / Q000008:administration & dosage / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008407:Mast Cells / Q000187:drug effects; D008784:Methysergide / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D011112:Polymyxin B / Q000633:toxicity; D013373:Substance P / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology / Q000633:toxicity; D003189:p-Methoxy-N-methylphenethylamine / Q000008:administration & dosage / Q000633:toxicity
D000880:Anthraquinones; D004365:Drugs, Chinese Herbal; D013373:Substance P; D003189:p-Methoxy-N-methylphenethylamine; D003907:Dexamethasone; D006632:Histamine; D004155:Diphenhydramine; D006003:Glycogen; D005966:Glucuronidase; D011112:Polymyxin B; D001920:Bradykinin; C073944:acetylshikonin; D007213:Indomethacin; D008784:Methysergide